Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
compound digestive enzyme capsules ii
- Development stage
- Unknown
- Lead developer
- Changzhou Qianhong Biopharma
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes, Small Molecules
- Administration
- Oral
01
Overview
Compound Digestive Enzyme Capsules II is an oral combination pharmaceutical product developed and manufactured by Changzhou Qianhong Biopharma for the treatment of digestive disorders. Marketed under the brand name Qianhong Yimei, the formulation consists of four active components: pepsin, pancreatin, cellulase, and ursodeoxycholic acid. Pepsin initiates protein digestion in the stomach, while pancreatin (containing amylase, lipase, and protease) facilitates the breakdown of carbohydrates, fats, and proteins in the alkaline environment of the small intestine. Cellulase assists in the digestion of plant-based fibers, and ursodeoxycholic acid acts as a choleretic to promote bile secretion and fat emulsification. This multi-enzyme approach is designed to alleviate symptoms of dyspepsia, such as bloating, loss of appetite, and postprandial fullness, by compensating for endogenous enzyme deficiencies.
- Brand names
- 千红怡美Qianhong Yimei
- Other names
- 复方消化酶胶囊（II）Compound Digestive Enzyme Capsules II
02
Targets
AMY (Pancreatic alpha-amylase)CellulasePEP (Pepsin)PNLIP (Pancreatic triacylglycerol lipase)
Beyond the preview
Go deeper on compound digestive enzyme capsules ii.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on compound digestive enzyme capsules ii.